Chronic renal failure: effect of hemodialysis on gastrointestinal hormones
- PMID: 6150657
- DOI: 10.1016/0002-9610(84)90426-4
Chronic renal failure: effect of hemodialysis on gastrointestinal hormones
Abstract
Fifteen patients with chronic renal failure (serum creatinine level greater than 5 mg/dl) of long duration (more than 2 years) requiring hemodialysis were studied. Blood samples before and after 4 hours of hemodialysis were assayed for creatinine, blood urea nitrogen, potassium, calcium, glucose, insulin, gastrin, gastric inhibitory polypeptide, vasoactive intestinal polypeptide, pancreatic polypeptide, somatostatin, motilin, and neurotensin levels. Before dialysis, serum gastrin was minimally increased whereas gastric inhibitory polypeptide and pancreatic polypeptide were grossly increased compared with normal fasting values. Hemodialysis produced no changes in serum gastric inhibitory polypeptide, vasoactive intestinal polypeptide, pancreatic polypeptide, somatostatin, motilin, and neurotensin. Slight increases in serum insulin and gastrin levels may have occurred secondary to a dialysis-induced increase in the serum calcium level. The kidneys appear to be a major site of inactivation of insulin, gastrin, gastric inhibitory polypeptide, and pancreatic polypeptide. The gastrin level, although elevated in renal failure patients, may be suppressed by very high circulating levels of gastric inhibitory polypeptide.
Similar articles
-
Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis.Scand J Gastroenterol. 1991 Jun;26(6):599-604. doi: 10.3109/00365529109043633. Scand J Gastroenterol. 1991. PMID: 1713707
-
Gut hormones in inflammatory bowel disease.Scand J Gastroenterol. 1983 Oct;18(7):845-52. doi: 10.3109/00365528309182104. Scand J Gastroenterol. 1983. PMID: 6374867
-
The effect of pirenzepine on meal-stimulated gastrointestinal hormones.Scand J Gastroenterol Suppl. 1980;66:57-61. Scand J Gastroenterol Suppl. 1980. PMID: 6113682 Clinical Trial.
-
Diurnal profiles of gastrointestinal regulatory peptides.Scand J Gastroenterol. 1985 Jan;20(1):1-4. doi: 10.3109/00365528509089624. Scand J Gastroenterol. 1985. PMID: 2859649 Review. No abstract available.
-
[Gastrointestinal hormones: present status].Med Lab (Stuttg). 1979 Apr;32(4):71-88. Med Lab (Stuttg). 1979. PMID: 220513 Review. German. No abstract available.
Cited by
-
Successful treatment of enterocutaneous fistula in a hemodialysis patient with somatostatin.Yonsei Med J. 2009 Dec 31;50(6):865-6. doi: 10.3349/ymj.2009.50.6.865. Epub 2009 Dec 18. Yonsei Med J. 2009. PMID: 20046434 Free PMC article.
-
Delayed gastric emptying in nondiabetic patients with end-stage kidney disease.Ren Fail. 2022 Dec;44(1):329-335. doi: 10.1080/0886022X.2022.2030754. Ren Fail. 2022. PMID: 35188060 Free PMC article.
-
Glucose-dependent insulinotropic polypeptide (GIP).Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28. Mol Metab. 2025. PMID: 40024571 Free PMC article. Review.
-
Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes.Biochem J. 2002 Nov 1;367(Pt 3):913-20. doi: 10.1042/BJ20020319. Biochem J. 2002. PMID: 12150711 Free PMC article.
-
Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.Int Urol Nephrol. 2013 Dec;45(6):1733-40. doi: 10.1007/s11255-013-0457-4. Epub 2013 May 14. Int Urol Nephrol. 2013. PMID: 23670285
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical